Cyclo Therapeutics, Inc.

NasdaqCM:CYTH Stock Report

Market Cap: US$20.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Cyclo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CYTH?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds1,501,6255.22%
Institutions2,265,9247.88%
Individual Insiders2,755,6249.58%
General Public9,246,68832.1%
Public Companies12,998,19445.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 67.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.2%
Rafael Holdings, Inc.
12,998,194US$9.4m44%no data
5.22%
Armistice Capital LLC
1,501,625US$1.1m0%0.03%
2.59%
N. Fine
743,804US$536.0k0%no data
2.4%
EPIQ Capital Group, LLC
689,447US$496.8k-6.76%0.13%
2.08%
The Vanguard Group, Inc.
598,694US$431.4k0%no data
2.05%
The Founders Fund, LLC
590,731US$425.7k0%17.7%
1.53%
Markus Sieger
440,260US$317.3k15.2%no data
1.46%
F. Ostronic
419,100US$302.0k16.5%no data
1.39%
C. Strattan
399,272US$287.7k-28.1%no data
0.62%
Randall Toig
179,137US$129.1k22.8%no data
0.6%
William Shanahan
173,966US$125.4k16.9%no data
0.53%
Geode Capital Management, LLC
152,332US$109.8k0%no data
0.47%
Shawn Cross
136,346US$98.3k26.5%no data
0.32%
Jeffrey Tate
92,042US$66.3k0%no data
0.29%
BlackRock, Inc.
83,822US$60.4k0.36%no data
0.27%
William Conkling
77,884US$56.1k55.1%no data
0.23%
Vivien Wong
64,853US$46.7k63.3%no data
0.15%
Two Sigma Securities, LLC, Asset Management Arm
42,541US$30.7k0%0.01%
0.14%
State Street Global Advisors, Inc.
39,530US$28.5k0%no data
0.076%
Northern Trust Global Investments
21,736US$15.7k0.06%no data
0.064%
Wealth Enhancement Advisory Services, LLC
18,285US$13.2k-21.9%no data
0.058%
Joshua Fine
16,560US$11.9k-2.01%no data
0.043%
Michael Lisjak
12,400US$8.9k0%no data
0.042%
UBS Asset Management AG
11,987US$8.6k-3.78%no data
0.023%
Tower Research Capital Europe Limited
6,684US$4.8k23.9%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/28 22:05
End of Day Share Price 2025/03/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cyclo Therapeutics, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Swayampakula RamakanthH.C. Wainwright & Co.
Jason McCarthyMaxim Group